This document is an excerpt from the EUR-Lex website
Document 32016B1536
Decision (EU) 2016/1536 of the European Parliament of 28 April 2016 on the closure of the accounts of the European Medicines Agency for the financial year 2014
Decision (EU) 2016/1536 of the European Parliament of 28 April 2016 on the closure of the accounts of the European Medicines Agency for the financial year 2014
Decision (EU) 2016/1536 of the European Parliament of 28 April 2016 on the closure of the accounts of the European Medicines Agency for the financial year 2014
IO L 246, 14.9.2016, p. 287–288
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
14.9.2016 |
EN |
Official Journal of the European Union |
L 246/287 |
DECISION (EU) 2016/1536 OF THE EUROPEAN PARLIAMENT
of 28 April 2016
on the closure of the accounts of the European Medicines Agency for the financial year 2014
THE EUROPEAN PARLIAMENT,
|
— |
having regard to the final annual accounts of the European Medicines Agency for the financial year 2014, |
|
— |
having regard to the Court of Auditors’ report on the annual accounts of the European Medicines Agency for the financial year 2014 together with the Agency’s reply (1), |
|
— |
having regard to the statement of assurance (2) as to the reliability of the accounts and the legality and regularity of the underlying transactions provided by the Court of Auditors for the financial year 2014, pursuant to Article 287 of the Treaty on the Functioning of the European Union, |
|
— |
having regard to the Council’s recommendation of 12 February 2016 on discharge to be given to the Agency in respect of the implementation of the budget for the financial year 2014 (05584/2016 – C8-0069/2016), |
|
— |
having regard to Article 319 of the Treaty on the Functioning of the European Union, |
|
— |
having regard to Regulation (EU, Euratom) No 966/2012 of the European Parliament and of the Council of 25 October 2012 on the financial rules applicable to the general budget of the Union and repealing Council Regulation (EC, Euratom) No 1605/2002 (3), and in particular Article 208 thereof, |
|
— |
having regard to Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (4), and in particular Article 68 thereof, |
|
— |
having regard to Commission Regulation (EC, Euratom) No 2343/2002 of 19 November 2002 on the framework Financial Regulation for the bodies referred to in Article 185 of Council Regulation (EC, Euratom) No 1605/2002 on the Financial Regulation applicable to the general budget of the European Communities (5), |
|
— |
having regard to Commission Delegated Regulation (EU) No 1271/2013 of 30 September 2013 on the framework financial regulation for the bodies referred to in Article 208 of Regulation (EU, Euratom) No 966/2012 of the European Parliament and of the Council (6), and in particular Article 108 thereof, |
|
— |
having regard to Rule 94 of and Annex V to its Rules of Procedure, |
|
— |
having regard to the report of the Committee on Budgetary Control and the opinion of the Committee on the Environment, Public Health and Food Safety (A8-0114/2016), |
1.
Notes that the final annual accounts of the European Medicines Agency are as annexed to the Court of Auditors’ report;
2.
Approves the closure of the accounts of the European Medicines Agency for the financial year 2014;
3.
Instructs its President to forward this decision to the Executive Director of the European Medicines Agency, the Council, the Commission and the Court of Auditors, and to arrange for its publication in the Official Journal of the European Union (L series).
The President
Martin SCHULZ
The Secretary-General
Klaus WELLE
(1) OJ C 409, 9.11.2015, p. 197.
(2) See footnote 1.
(3) OJ L 298, 26.10.2012, p. 1.
(4) OJ L 136, 30.4.2004, p. 1.